Yanxin Luo

2.8k total citations · 1 hit paper
88 papers, 2.0k citations indexed

About

Yanxin Luo is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yanxin Luo has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 31 papers in Molecular Biology and 29 papers in Surgery. Recurrent topics in Yanxin Luo's work include Colorectal Cancer Surgical Treatments (22 papers), Colorectal Cancer Screening and Detection (19 papers) and Epigenetics and DNA Methylation (15 papers). Yanxin Luo is often cited by papers focused on Colorectal Cancer Surgical Treatments (22 papers), Colorectal Cancer Screening and Detection (19 papers) and Epigenetics and DNA Methylation (15 papers). Yanxin Luo collaborates with scholars based in China, United States and South Africa. Yanxin Luo's co-authors include William M. Grady, Yumo Xie, Huichuan Yu, Meijin Huang, Andrew M. Kaz, Slavomir Dzieciatkowski, Xiaolin Wang, Xiaosheng He, Lishuo Shi and Jianping Wang and has published in prestigious journals such as Journal of Neuroscience, Gastroenterology and PLoS ONE.

In The Last Decade

Yanxin Luo

83 papers receiving 2.0k citations

Hit Papers

Gastrointestinal cancers in China, the USA, and Europe 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanxin Luo China 26 892 865 491 406 368 88 2.0k
Andrea Remo Italy 26 754 0.8× 586 0.7× 426 0.9× 240 0.6× 379 1.0× 76 1.7k
Yoshiyuki Fujiwara Japan 31 760 0.9× 1.1k 1.2× 683 1.4× 844 2.1× 310 0.8× 82 2.6k
Shangli Cai China 21 990 1.1× 615 0.7× 544 1.1× 197 0.5× 158 0.4× 110 1.9k
Ken Op de Beeck Belgium 29 738 0.8× 1.1k 1.3× 372 0.8× 173 0.4× 204 0.6× 77 2.2k
Maria Ausiliatrice Puglisi Italy 18 598 0.7× 459 0.5× 268 0.5× 443 1.1× 110 0.3× 38 1.5k
Hendrik Seeliger Germany 24 902 1.0× 609 0.7× 235 0.5× 567 1.4× 107 0.3× 64 1.8k
Gabriella Cadoni Italy 29 607 0.7× 695 0.8× 315 0.6× 317 0.8× 127 0.3× 70 2.1k
S. Baba Japan 27 705 0.8× 739 0.9× 264 0.5× 969 2.4× 618 1.7× 149 2.8k
Veerle Melotte Netherlands 26 573 0.6× 1.6k 1.9× 570 1.2× 288 0.7× 408 1.1× 53 2.4k
Atsuko Kasajima Japan 27 870 1.0× 598 0.7× 342 0.7× 235 0.6× 149 0.4× 97 1.8k

Countries citing papers authored by Yanxin Luo

Since Specialization
Citations

This map shows the geographic impact of Yanxin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxin Luo more than expected).

Fields of papers citing papers by Yanxin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxin Luo. The network helps show where Yanxin Luo may publish in the future.

Co-authorship network of co-authors of Yanxin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxin Luo. A scholar is included among the top collaborators of Yanxin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxin Luo. Yanxin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yufei, et al.. (2025). Modulation of renal fibrosis-related signaling pathways by traditional Chinese medicine: molecular mechanisms and experimental evidence. International Urology and Nephrology. 57(10). 3263–3286. 1 indexed citations
2.
Peng, Shaoyong, Xiaoxia Liu, Yingjie Li, et al.. (2023). Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes. Cancer Medicine. 12(9). 10303–10314. 2 indexed citations
4.
Xie, Yumo, Jinxin Lin, Ning Zhang, et al.. (2023). Prevalent Pseudoprogression and Pseudoresidue in Patients With Rectal Cancer Treated With Neoadjuvant Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network. 21(2). 133–142.e3. 23 indexed citations
5.
Liu, Zongchao, Juan Li, Xiaolin Wang, et al.. (2021). Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer. Journal of Translational Medicine. 19(1). 256–256. 17 indexed citations
6.
Li, Yingjie, Liangliang Bai, Huichuan Yu, et al.. (2020). Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer. Cancer Research. 80(23). 5203–5215. 15 indexed citations
7.
Yu, Huichuan, Qi Zou, Zenghong Huang, et al.. (2020). <p>Nomograms for Prediction of Molecular Phenotypes in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 309–321. 5 indexed citations
8.
Huang, Zenghong, Xiaolin Wang, Qi Zou, et al.. (2020). High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer. International Journal of Colorectal Disease. 35(4). 695–704. 18 indexed citations
9.
Luo, Wei, Yanxin Luo, Zhiming Ma, & Rencheng Wang. (2020). Organizational Learning and Audit Quality: Evidence from the Spillover Effects of Auditing Cross-Listed Clients. SSRN Electronic Journal.
10.
Gao, Xianhua, Yanxin Luo, Luo Yang, et al.. (2019). Comparison of three-dimensional versus two-dimensional laparoscopic surgery for rectal cancer: a meta-analysis. International Journal of Colorectal Disease. 34(9). 1577–1583. 5 indexed citations
11.
Li, Juan, et al.. (2019). Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World Journal of Gastroenterology. 25(1). 118–137. 29 indexed citations
12.
Luebeck, E. Georg, William D. Hazelton, Kit Curtius, et al.. (2018). Implications of Epigenetic Drift in Colorectal Neoplasia. Cancer Research. 79(3). 495–504. 24 indexed citations
13.
14.
Bosch, Linda J.W., Yanxin Luo, Victoria Valinluck Lao, et al.. (2016). WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. Clinical Cancer Research. 22(18). 4612–4622. 6 indexed citations
15.
Kang, Liang, Wen‐Hao Chen, Shuangling Luo, et al.. (2015). Transanal total mesorectal excision for rectal cancer: a preliminary report. Surgical Endoscopy. 30(6). 2552–2562. 23 indexed citations
16.
Li, Qianqian, Chiao‐Yin Sun, Yanxin Luo, et al.. (2014). A Conjugate Vaccine Attenuates Morphine- and Heroin-Induced Behavior in Rats. The International Journal of Neuropsychopharmacology. 18(5). pyu093–pyu093. 27 indexed citations
17.
Luo, Yanxin, Karen D. Tsuchiya, Samornmas Kanngurn, et al.. (2012). RET is a potential tumor suppressor gene in colorectal cancer. Oncogene. 32(16). 2037–2047. 69 indexed citations
18.
Luo, Yanxin, Ji Cui, Chuangqi Chen, et al.. (2011). Clinical Outcomes after Surgical Resection of Colorectal Cancer in 1,294 Patients. Hepatogastroenterology. 59(117). 1398–402. 12 indexed citations
19.
Chen, Dianke, Jiachun Lü, Yanxin Luo, et al.. (2011). Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Carcinogenesis. 32(7). 1043–1049. 9 indexed citations
20.
Luo, Yanxin, Ji Cui, Lei Wang, et al.. (2009). Identification of cancer‐associated proteins by proteomics and downregulation of β‐tropomyosin expression in colorectal adenoma and cancer. PROTEOMICS - CLINICAL APPLICATIONS. 3(12). 1397–1406. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026